188 related articles for article (PubMed ID: 31437703)
21. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
Trials; 2013 Jul; 14():224. PubMed ID: 23866851
[TBL] [Abstract][Full Text] [Related]
22. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AWF
Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
[TBL] [Abstract][Full Text] [Related]
23. EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study.
Jensen KHR; Urdanibia-Centelles O; Dam VH; Köhler-Forsberg K; Frokjaer VG; Knudsen GM; Jørgensen MB; Ip CT
Eur Neuropsychopharmacol; 2024 Feb; 79():59-65. PubMed ID: 38128462
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
Shelton RC; Haman KL; Rapaport MH; Kiev A; Smith WT; Hirschfeld RM; Lydiard RB; Zajecka JM; Dunner DL
J Clin Psychiatry; 2006 Nov; 67(11):1674-81. PubMed ID: 17196045
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
[TBL] [Abstract][Full Text] [Related]
26. Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Di Nicola M; Dell'Osso B; Peduto I; Cipelli R; Pugliese AC; Signorelli MS; Ventriglio A; Martinotti G
Curr Neuropharmacol; 2023; 21(3):727-739. PubMed ID: 35410606
[TBL] [Abstract][Full Text] [Related]
27. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Zhou C; Zhong J; Zou B; Fang L; Chen J; Deng X; Zhang L; Zhao X; Qu Z; Lei Y; Lei T
PLoS One; 2017; 12(2):e0172270. PubMed ID: 28241064
[TBL] [Abstract][Full Text] [Related]
28. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
[TBL] [Abstract][Full Text] [Related]
29. Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder.
Korgaonkar MS; Goldstein-Piekarski AN; Fornito A; Williams LM
Mol Psychiatry; 2020 Jul; 25(7):1537-1549. PubMed ID: 31695168
[TBL] [Abstract][Full Text] [Related]
30. Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
McRae K; Rekshan W; Williams LM; Cooper N; Gross JJ
J Affect Disord; 2014 Apr; 159():127-32. PubMed ID: 24679400
[TBL] [Abstract][Full Text] [Related]
31. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
Mokhber N; Abdollahian E; Soltanifar A; Samadi R; Saghebi A; Haghighi MB; Azarpazhooh A
Pharmacopsychiatry; 2014 Jul; 47(4-5):131-40. PubMed ID: 24955552
[TBL] [Abstract][Full Text] [Related]
32. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
[TBL] [Abstract][Full Text] [Related]
34. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM
Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948
[TBL] [Abstract][Full Text] [Related]
35. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
[TBL] [Abstract][Full Text] [Related]
36. An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):350-3. PubMed ID: 20562780
[TBL] [Abstract][Full Text] [Related]
37. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
[TBL] [Abstract][Full Text] [Related]
38. Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Nakajima S; Uchida H; Suzuki T; Watanabe K; Hirano J; Yagihashi T; Takeuchi H; Abe T; Kashima H; Mimura M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1983-9. PubMed ID: 21889560
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M; Trivedi M; Daly EJ; Melkote R; Lane R; Lim P; Vitagliano D; Blier P; Fava M; Liebowitz M; Ravindran A; Gaillard R; Ameele HVD; Preskorn S; Manji H; Hough D; Drevets WC; Singh JB
Int J Neuropsychopharmacol; 2019 Oct; 22(10):616-630. PubMed ID: 31290965
[TBL] [Abstract][Full Text] [Related]
40. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
